TWO SIGMA INVESTMENTS, LP

Position in IPSC — Century Therapeutics, Inc.

CIK 1179392 NEW YORK, NY

Position in IPSC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,612,581

+$1,253,150 QoQ

Shares Held

2,699,013

+13.8% QoQ

Ownership

1.49%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#19

of 98 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,273,664,878 across 342 Biotechnology names. IPSC ranks #102 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,612,581	2,699,013	+13.8%	Shares	Sole	2026-08-14
2026-03-31	$5,359,431	2,371,430	+58.5%	Shares	Sole	2026-05-15
2025-12-31	$1,488,436	1,495,916	+64.1%	Shares	Sole	2026-02-17
2025-09-30	$453,900	911,446	+59.2%	Shares	Sole	2025-11-14
2025-06-30	$320,052	572,544	+565.7%	Shares	Sole	2025-08-14
2025-03-31	$40,938	86,006	+28.8%	Shares	Sole	2025-05-15
2024-12-31	$67,464	66,797	+321.1%	Shares	Sole	2025-02-14
2023-06-30	$50,130	15,864	-57.4%	Shares	Sole	2023-08-14
2023-03-31	$129,146	37,218	+3.8%	Shares	Sole	2023-05-15
2022-12-31	$183,972	35,862	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.